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p53 regulates expression of uncoupling protein 1 through binding and repression of PPARγ coactivator 1α 1 
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Background: Expression and activation of UCP1 in 22 
adipocytes increase energy expenditure through 23 
uncoupled respiration. 24 
Results: Lack of p53 leads to increased expression 25 
of UCP1 in the inguinal white adipose tissue. 26 
Conclusion: Through regulation of the coactivator 27 
function of PPARGC1a and PPARGC1b p53 28 
modulates Ucp1 expression in white adipose tissue.  29 
Significance: Extends the growing list of metabolic 30 
processes regulated by the tumor suppressor p53. 31 
 32 
ABSTRACT 33 
The tumor suppressor p53 (TRP53 in mice) is 34 
known for its involvement in carcinogenesis, but 35 
work during recent years has underscored the 36 
importance of p53 in the regulation of whole 37 
body metabolism. A general notion is that p53 is 38 
necessary for efficient oxidative metabolism. The 39 
importance of UCP1-dependent uncoupled 40 
respiration and increased oxidation of glucose 41 
and fatty acids in brown or brown-like, termed 42 
BRITE or beige, adipocytes in relation to energy 43 
balance and homeostasis has recently been 44 
highlighted. UCP1-dependent uncoupled 45 
respiration in classic interscapular brown 46 
adipose tissue is central to cold-induced 47 
thermogenesis, whereas BRITE/beige adipocytes 48 
are of special importance in relation to diet-49 
induced thermogenesis, where the importance of 50 
UCP1 is only clearly manifested in mice kept at 51 
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thermoneutrality. We challenged wildtype and 52 
TRP53-deficient mice by high fat feeding under 53 
thermoneutral conditions. Interestingly, mice 54 
lacking TRP53 gained less weight compared to 55 
their wildtype counterparts. This was related to 56 
an increased expression of Ucp1 and other 57 
PPARGC1a and PPARGC1b target genes, but 58 
not Ppargc1a or Ppargc1b in inguinal white 59 
adipose tissue of mice lacking TRP53. We show 60 
that TRP53, independently of its ability to bind 61 
DNA, inhibits the activity of PPARGC1a and 62 
PPARGC1b.  Collectively, our data shows that 63 
TRP53 has the ability to regulate the 64 
thermogenic capacity of adipocytes through 65 
modulation of PPARGC1 activity. 66 
 67 
INTRODUCTION 68 
Analyses of several genetically modified mouse 69 
models have during the last decades shown that 70 
predisposition to obesity can be regulated 71 
independently of food intake and physical activity 72 
(62). A large proportion of these mice show 73 
enhanced expression and/or activation of the 74 
uncoupling protein 1 (UCP1) (6). UCP1 functions as 75 
a proton channel in the inner mitochondrial 76 
membrane by-passing the normal ATP-production 77 
resulting in heat-production. Due to the possible 78 
beneficial effect of UCP1 in relation to the treatment 79 
of obesity, understanding its modes of function and 80 
regulation has been an area of intense interest.  81 
The peroxisome proliferator-activated receptor γ 82 
coactivator 1α (PPARGC1a) plays a pivotal role in 83 
the control of Ucp1 expression (35). Activation of 84 
this cofactor leads to the induction of not only Ucp1 85 
but also several genes involved in mitochondrial 86 
function including β-oxidation. The more recent 87 
family member, PPARGC1b, has been shown to 88 
share some, but not all functions with PPARGC1a in 89 
the regulation of the thermogenic program. 90 
However, complete attenuation of Ucp1 expression 91 
in brown adipocytes requires ablation of both 92 
Ppargc1a and Ppargc1b, emphasizing an important 93 
role for PPARGC1a and PPARGC1b in controlling 94 
the expression of Ucp1 (57). The ability of 95 
PPARGC1a to induce Ucp1 expression is not 96 
limited to murine models as demonstrated by 97 
analysis of cells of human origin (3). 98 
PPARGC1a was recently shown to act as a cofactor 99 
for the tumor suppressor p53, regulating the balance 100 
between cell cycle arrest and apoptosis downstream 101 
of p53-activation (54). Their interplay has also been 102 
emphasized by DePinho and colleagues showing 103 
TRP53-mediated regulation of Ppargc1a and 104 
Ppargc1b expression (51). p53 was for long 105 
regarded mainly as a dormant regulator of cell 106 
cycling and apoptosis activated in response to a 107 
variety of cellular stresses (26). However, an 108 
increasing number of articles has demonstrated a 109 
pivotal role for p53 as a regulator of metabolism in 110 
unstressed cells. Overall, data suggest that p53 111 
supports oxidative metabolism (5). Notably, livers 112 
of mice deficient for TRP53 have lowered 113 
expression of synthesis of cytochrome c oxidase 2 114 
(Sco2), which is essential for assembly of the 115 
mitochondrial cytochrome oxidase complex in the 116 
electron transport chain, and hence, oxidative 117 
metabolism (40). 118 
It was recently reported that lack of TRP53 impaired 119 
expression of UCP1 and the development of 120 
interscapular brown adipose tissue, and accordingly, 121 
TRP53 was reported to protect mice against diet-122 
induced obesity (43). Others and we have 123 
emphasized the importance of UCP1 expressing 124 
BRITE or beige adipocytes in white adipose depots 125 
in relation to protection against diet-induced obesity 126 
(38, 59). Of note, work by Cannon and Nedergaard 127 
has clearly demonstrated that the role of UCP1 in 128 
relation to diet-induced obesity is only observable 129 
when mice are kept at thermoneutral conditions 130 
(18).  131 
Therefore, we decided to examine the phenotype of 132 
TRP53-deficient mice on a C57BL/6J background 133 
challenged with a high fat diet and kept under 134 
thermoneutral conditions.  135 
Contrasting results obtained at room temperature by 136 
Rotter and coworkers (43), we observed that 137 
TRP53-deficient mice compared with wildtype mice 138 
were resistant to diet-induced obesity. Mice lacking 139 
TRP53 had augmented expression of Ucp1 mRNA 140 
in their inguinal white adipose tissue. Furthermore, 141 
TRP53 could independently of its DNA-binding 142 
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ability repress the activity of PPARGC1a and 143 
thereby oxidative metabolism. Thus, our data 144 
suggest a tissue-specific involvement of TRP53 in 145 
its regulation of metabolism.  146 
 147 
EXPERIMENTAL PROCEDURES 148 
Cell culture and differentiation 149 
Wildtype and TRP53-deficient mouse embryonic 150 
fibroblasts (MEFs) were generous gifts from Dr. 151 
Stephen N. Jones. MEFs were grown and 152 
differentiated as described elsewhere (24). 153 
 154 
Plasmids 155 
pCMVNeoBam-Trp53 and -Trp53 R175D were 156 
generous gifts from Dr. Thierry Souissi. Trp53 and 157 
Trp53 R175D were amplified using Primestar 158 
(Takara) according to manufacturer’s instructions, 159 
inserted into pBluescript, sequenced, and moved 160 
into pBABE-puro (kindly granted by Dr. Ormond A. 161 
MacDougald). pBABE-puro TAg and pBABE-puro 162 
TAg K1 were described previously (23). TAg Δ was 163 
moved from pBABE-neo TAg Δ (kindly provided 164 
by Dr. Robert A. Weinberg) and insert into pBABE-165 
puro. pCMX-Gal4-Ppargc1a was a generous gift 166 
from Dr. Dan Kelly. UASx4-TK luc was kindly 167 
supplied by Dr. Ronald M. Evans. Fragments of 168 
Ppargc1a were amplified by PCR using Primestar 169 
(Takara) and inserted into pGEX-5X-1 (GE 170 
Healthcare). pMD2.G, pMDLg/pRRE and pRSV-171 
Rev were purchased from Addgene. pSicoR-lacZ,  172 
pSicoR-PPARGC1a I and pSicoR-PPARGC1a II 173 
were generous gifts from Dr. Susanne Mandrup. 174 
 175 
Retro- and lentiviral transductions 176 
Retroviral transduction was done as described 177 
previously with puromycin selection for two days 178 
(25). Lentiviral particles were produced as described 179 
(60). Lentiviral transduction was confirmed by 180 
inspection for GFP expression. 181 
 182 
GST-pull down 183 
Fusion proteins were expressed in Escherichia coli 184 
by induction with 0.1 mM isopropyl β-D-185 
thiogalactosidase at 30 °C, cells were lysed by 186 
sonication, and incubated with Glutathione 187 
Sepharose (GE Healthcare). TRP53 was in vitro 188 
translated (TnT, Promega) in the presence of [35S]-189 
methionine (Amersham). Beads and in vitro 190 
translated proteins were incubated in pull down 191 
buffer (20 mM Tris-HCl, pH 8.0; 100 mM NaCl; 10 192 
mM EDTA; 0.5% NP-40; 10 mM DTE; 1% skim-193 
milk and protease inhibitors (Complete, Roche)) for 194 
2 hours at 4 °C. Beads were washed once with pull-195 
down buffer supplemented with skimmed milk and 196 
twice with pull-down buffer without skimmed milk, 197 
boiled in SDS-lysis buffer and resolved using SDS-198 
PAGE. [35S]-methionine-labelled proteins were 199 
visualized by autoradiography. 200 
 201 
Fatty acid oxidation 202 
Mitochondrial fatty acid oxidation was measured by 203 
14CO2 trapping from sealed culture flasks where 204 
medium was supplemented with 1-14C-labelled 205 
palmitic acid (0.25 µCi/ml) and 500 µM L-carnitine 206 
as described elsewhere (4). 207 
 208 
RNA purification, reverse transcription, and real-209 
time PCR 210 
RNA was purified using TRIzol (Invitrogen) 211 
according to manufacturer’s instructions. Reverse 212 
transcription was performed essentially as described 213 
elsewhere (39). Quantitative PCR was performed in 214 
25 μl reactions containing SYBR® Green 215 
JumpStart™ Taq ReadyMix™ (Sigma-Aldrich), 1.5 216 
μl of diluted cDNA and 300 nM of each primer. 217 
Reaction mixtures were preheated at 95 °C for 2 min 218 
followed by 40 cycles of melting at 94 °C for 15 s, 219 
annealing at 60 °C for 30 s, elongation at 72 °C for 220 
45 s. Primer sequences are available on request. 221 
Unless stated otherwise expression of TATA-box-222 
binding protein (Tbp) mRNA was used for 223 
normalization. 224 
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 225 
Western blotting 226 
Western blotting was performed as described 227 
previously (24). Primary antibody was UCP1 228 
(Chemicon), TFIIB (Santa Cruz), Annexin II (Santa 229 
Cruz), TRP53 (Cell Signaling) and α-tubulin 230 
(Sigma-Aldrich). Secondary antibody was 231 
horseradish peroxidase-conjugated antibodies 232 
(DAKO). Quantification was done using the ImageJ 233 
software. 234 
 235 
Isolation and culture of primary adipocytes 236 
Primary brown (from interscapular, cervical and 237 
axillary BAT) and inguinal white pre-adipocytes 238 
from 6-7 weeks old TRP53 deficient male mice 239 
(B6.129-Trp53tm1BrdN12, Taconic Biosciences) and 240 
corresponding wildtypes were isolated and cultured 241 
essentially as described elsewhere (8). Five weeks 242 
old mice were acclimated 1-2 weeks before they 243 
were sacrificed and used for isolation of adipose 244 
depots. After mincing the tissue was transferred to a 245 
HEPES-buffered solution (pH 7.4) containing 0.2% 246 
crude collagenase type II (Sigma-Aldrich) and 247 
digested at 37 °C for 30 min with constant shaking. 248 
The suspension was filtered (250-μm) and incubated 249 
on ice for 15 min to separate the mature adipocytes 250 
and the stromal vascular (SV) fraction. The SV 251 
fraction was then filtered through a 50-μm filter. 252 
Cells were pelleted (10 min, 700 G), resuspended in 253 
culture medium (DMEM, 4.5 g D-glucose/liter) 254 
(Sigma-Aldrich), 10% newborn calf serum (Life 255 
Technologies), 2.4 nM insulin (Novo Nordisk), 4 256 
mM L-glutamine, 10 mM HEPES (Lonza), 25 μg/ml 257 
sodium ascorbate (Sigma-Aldrich), 50 IU/ml 258 
penicillin and 50 μg/ml streptomycin, centrifuged. 259 
resuspended in culture medium and plated in 6-well 260 
plates. Cultures were incubated in a humidified 261 
atmosphere of 8% CO2 at 37 °C. Medium was 262 
changed 1, 3, 4 and 6 days after isolation. On day 4 263 
and 6 the medium was supplemented with 500 nM 264 
rosiglitazone, and 5 ug/ml insulin. On day 8 the 265 
mature adipocytes were trypsinized, counted and 266 
replated in a gelatin coated seahorse plate. 267 
 268 
Seahorse measurements 269 
Two days after replating, real-time measurements of 270 
oxygen consumption rate (OCR) were performed 271 
using the Seahorse XF96 Extracellular Flux 272 
Analyzer (Seahorse Bioscience). One hour before 273 
the first measurement, the cell culture medium was 274 
changed to DMEM (Seahorse Bioscience) adjusted 275 
to 5 mM glucose (Sigma-Aldrich) and pH 7.4. OCR 276 
was measured under basal conditions and during 277 
successive adjustment to 1 µM isoproterenol 278 
(Sigma-Aldrich), 1 µM FCCP and a mixture of 1 279 
µM rotenone and 1 µM antimycin A (Seahorse 280 
Bioscience). 281 
  282 
Mice and feeding 283 
In separate experiments, eight wildtype and eight 284 
Trp53 null mice on a pure C57BL/6J background 285 
were purchased from either the Jackson Laboratory 286 
or Taconic Biosciences (strain designation 287 
B6.129S2-Trp53tm1Tyj/J or B6.129-Trp53tm1BrdN12, 288 
respectively). The mice were housed at 289 
thermoneutrality (28±2ºC), caged individually and 290 
fed either a regular chow or a high-fat diet (45% 291 
kcal fat, D12451, Research Diets) ad libitum. The 292 
feeding experiments were initiated when the mice 293 
were 9-10 weeks of age after acclimatization for 7 294 
days in the animal facility. Feed intake was recorded 295 
three times a week and the mice were weighed once 296 
a week. After six weeks of feeding the mice were 297 
sacrificed by cardiac puncture under anesthesia 298 
(subcutaneous injection of 0.1 ml 1:1 299 
Hypnorm:Dormicum per 10 grams of body weight). 300 
Blood was collected in tubes containing EDTA 301 
(Medinor AS, Oslo, Norway), centrifuged at 2500 g 302 
in 4°C for 5 min. Plasma was stored at -80°C until 303 
analyzed by commercial available enzymatic kits 304 
(Dialab, Vienne, Austria) using an autoanalyzer 305 
(MaxMat SA, Montpellier, France). Liver, muscle 306 
and adipose tissues were dissected out, weighed, 307 
snap-frozen in liquid nitrogen and stored at -80°C 308 
until further analyses. A portion of each adipose 309 
depot was fixed for histology. See histology section 310 
for further details. Glucose- and insulin tolerance 311 
tests were performed after 6h feed deprivation and 312 
in the fed state, respectively as described earlier (19) 313 
in a separate set of animals. 314 
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To examine the effect of housing temperature, three 315 
wild type mice and three Trp53 null mice (strain 316 
designation B6.129-Trp53tm1BrdN12) on a pure 317 
C57BL/6J background were purchased from 318 
Taconic Biosciences and fed a regular chow diet 319 
until 6 weeks of age. The mice were sacrificed by 320 
cervical dislocation. Interscapular brown adipose 321 
tissue was dissected out, snap-frozen in liquid 322 
nitrogen and stored at -80°C until further analyses. 323 
Experiments were approved by the Animal 324 
Experiment Inspectorate in Denmark and the 325 
Norwegian Animal Research Authority in 326 
compliance with the European convention for the 327 
protection of vertebrate animals used for 328 
experiments and other scientific purposes (Council 329 
of Europe, no. 123, Strasbourg, France, 1985). 330 
 331 
Indirect calorimetry 332 
VO2 and VCO2 were measured in open-circuit 333 
indirect calorimetry cages as described previously 334 
(34). In short, the mice were housed in CaloCages 335 
(Phenomaster, TSE Systems). Measurements were 336 
performed for a total of 72h. The first 24h were 337 
regarded as an adaptation period and only the 338 
subsequent 48h were used for analyses. 339 
 340 
Histological analyses 341 
Sections of liver, inguinal white adipose tissue 342 
(iWAT), epididymal white adipose tissue (eWAT) 343 
and interscapular brown adipose tissue (iBAT) were 344 
fixed in 4% formaldehyde in 0.1 M phosphate 345 
buffer, pH 7.4 overnight, rinsed and stored in 0.1 M 346 
phosphate buffer, pH 7.4. Paraffin-embedded 347 
sections were stained with hematoxilin and eosin 348 
and/or incubated with UCP1 antibody according to 349 
standard procedures (11). Dewaxed sections were 350 
processed as follows: 1) hydrogen peroxide 0.3% in 351 
methanol for 30 min to block  endogenous 352 
peroxidase; 2) normal rabbit serum (UCP1) 1:75 for 353 
20 min to reduce nonspecific background staining; 354 
3)  sheep anti-rat antibody against UCP1 (kindly 355 
provided by Dr. D. Ricquier, Paris, France) diluted 356 
1:3500 in PBS overnight at 4°C; 4) biotinylated 357 
secondary antibodies: rabbit anti-sheep IgG (UCP1) 358 
(Vector Laboratories; Burlingame, CA) 1:200 in 359 
PBS for 30 min; 5) ABC complex for 1 h 360 
(Vectastain ABC Kit, Vector Labs); 6) 361 
histochemical visualization of peroxidase using 3,3’-362 
diaminobenzidine hydrochloride cromogen 363 
according to supplier’s protocol (Sigma, St Louis, 364 
MO). Sections were counterstained with 365 
haematoxylin. The ability of the antibodies to 366 
specifically detect the antigens was evaluated in 367 
sections of tissues known to contain the antigens 368 
(such as the iBAT obtained from mice kept at 6°C 369 
for 10 days). Negative controls were obtained in 370 
each instance by omitting the primary antibody and 371 
using preimmune instead of primary antiserum 372 
Adipocyte size was calculated as the mean 373 
adipocyte area of 200 random adipocytes in each 374 
section using a drawing tablet and the Nikon LUCIA 375 
IMAGE (version 4.61, Laboratory Imaging, Czech 376 
Republic) of the morphometric program. Tissue 377 
sections were observed with a Nikon Eclipse E800 378 
light microscope using a x20 objective, and digital 379 
images were captured with a Nikon DXM 1200 380 
camera. 381 
The estimated, relative number of adipocytes in the 382 
epididymal white adipose stores was calculated by 383 
dividing the relative mass of the depot with the 384 
relative mass of individual adipocytes. This was 385 
estimated by converting the cell area into volume by 386 
assuming spherical shape of the adipocytes and 387 
similar density in wildtype and Trp53-/- mice. 388 
 389 
Statistical analysis 390 
Error bars represent standard error of the mean 391 
unless specified otherwise. Student’s t-test was used 392 
unless stated otherwise to determine statistical 393 
significance. Each experiment was performed at 394 
least two independent times.  395 
 396 
RESULTS 397 
TRP53-deficient mice gain less weight than wildtype 398 
mice when fed a high-fat diet 399 
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We challenged mice harboring and lacking Trp53 on 400 
a pure C57BL/6J background with either a regular 401 
chow or a high-fat diet under thermoneutral 402 
conditions. This mouse strain is highly susceptible 403 
to develop obesity and associated complications 404 
when fed excess calories. After 6 weeks of high fat 405 
feeding, TRP53-deficient mice on the high-fat diet 406 
were slimmer by macroscopic inspection and had 407 
gained significantly less body mass compared to 408 
their wildtype counterparts (Figure 1A+B). We 409 
observed no difference in the mice kept on chow. 410 
All mice used were 9-10 weeks of age at the onset 411 
of the experiment to avoid interference from 412 
possible tumor development in TRP53-deficient 413 
mice which happens at high rate later in life (14). 414 
To verify that the reduced body mass gain in the 415 
high-fat fed mice was not simply due to reduced 416 
energy intake and/or reduced fat absorption, feed 417 
intake and stool fat content were measured. 418 
Interestingly, the fat content in stool from TRP53-419 
deficient mice was lower than that in stool from 420 
wildtype mice (Figure 1C). As the feed intake was 421 
similar in the two groups of mice (Figure 1D), the 422 
decreased body mass gain indicated lowered feed 423 
efficiency in mice lacking TRP53 (Figure 1E).  424 
Obesity is usually accompanied by decreased insulin 425 
sensitivity and impaired glucose homeostasis. The 426 
levels of serum glucose in the fed state were not 427 
statistically different between the two mice 428 
genotypes (Figure 1F). During the short feeding 429 
period, the absence of TRP53 did not affect glucose 430 
tolerance (Figure 1G). However, we did observe an 431 
increased glucose clearance in TRP53-deficient 432 
mice subjected to an insulin-tolerance test (Figure 433 
1H) in agreement with previous findings (41) 434 
although there was no effect on the initial glucose 435 
disappearance rate (kITT) (wildtype: 436 
1.76±0.40%/min and Trp53-/-: 2.82±0.92%/min, 437 
S.E.M.). 438 
Surplus energy is stored as triglycerides in adipose 439 
tissues. Interestingly, the masses of adipose depots 440 
were decreased in mice lacking TRP53 but only in 441 
mice kept on the high-fat diet (Figure 2A). 442 
The decreased mass of adipose depots could 443 
potentially be caused by defective adipogenesis in 444 
mice lacking TRP53. This assumption is, however, 445 
contradicted by the inhibitory effect of TRP53 on 446 
adipocyte differentiation reported by us and others 447 
(22, 43, 44). Furthermore, in keeping with in vitro 448 
findings, TRP53-deficient mice had an increased 449 
number of adipocytes in their adipose stores 450 
although the fat cells were smaller in size (Figure 451 
2B-D) arguing against decreased adipogenesis in the 452 
TRP53-deficient mice.  453 
During histological inspection of the white adipose 454 
stores, we furthermore observed decreased 455 
macrophage infiltration in the epididymal white 456 
adipose tissue (eWAT) of TRP53-deficient mice 457 
(Figure 2E). This finding was strengthened by 458 
decreased macrophage marker gene expression in 459 
the adipose stores of TRP53-deficient mice (Figure 460 
2F). The decreased infiltration was in agreement 461 
with the improved ability of TRP53-deficient mice 462 
to cope with the high-fat feeding. 463 
The lower adipose mass could then reflect impaired 464 
uptake of fatty acids in adipocytes, which 465 
presumably would lead to increased circulating 466 
levels and/or ectopic systemic deposition of fatty 467 
acids. Therefore, we measured the concentrations of 468 
triglycerides, free fatty acids, and glycerol in 469 
wildtype and TRP53-deficient mice. Plasma levels 470 
of triglycerides, free fatty acids, and glycerol were 471 
similar in mice of the both genotypes (Figure 1F). 472 
Furthermore, we observed no signs of steatosis in 473 
the livers of TRP53-deficient mice. Rather, 474 
histological examination revealed the presence of 475 
lipid droplets only in livers from wildtype mice 476 
(Figure 3A). 477 
Fatty acids can be converted into ketone bodies in 478 
the liver. However, it is unlikely that the absence of 479 
steatosis in TRP53-deficient mice was caused by 480 
increased channeling of lipid into ketone body 481 
production as we found no significant difference in 482 
the plasma-level of OH-butyrate, the prime ketone 483 
body, between mice harboring or lacking TRP53 484 
(Figure 1F). Furthermore, mRNA levels for the rate-485 
limiting enzymes in ketone body production, acetyl-486 
CoA acyltransferase 2 (Acaa2) and 3-hydroxy-3-487 
methylglutaryl-CoA synthase 2 (Hmgcs2), were 488 
similar in mice of both genotypes (Figure 3B). 489 
Collectively, these results show that at 490 
thermoneutrality TRP53-deficient mice were 491 
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protected against obesity and associated 492 
complications normally imposed by high-fat 493 
feeding.  494 
 495 
Tissue-specific regulation of metabolic genes by 496 
TRP53 497 
Rather than being stored, lipids can be catabolized 498 
in the adipose tissues through UCP1-dependent 499 
uncoupled respiration generating heat instead of 500 
ATP. This occurs in a subset of adipose stores, most 501 
notably in the brown adipose tissue (BAT) in 502 
relation to cold-induced thermogenesis, but 503 
accumulating evidence point to induction of UCP1 504 
expression also in white depots as an important 505 
response to counteract diet-induced obesity (2, 38, 506 
59).  507 
We therefore speculated whether TRP53-deficient 508 
mice had altered expression of genes associated with 509 
thermogenesis. We found no differences in 510 
interscapular BAT (iBAT) (Figure 4A). This 511 
contrasted a recent report showing that TRP53 was 512 
required for normal iBAT development and UCP1 513 
expression (43). However, these mice were not 514 
housed at thermoneutrality (V. Rotter, personal 515 
communication). To examine if housing temperature 516 
could underlay the different effects observed in 517 
response to Trp53 ablation, we measured expression 518 
of Ucp1 and other iBAT marker genes in wildtype 519 
and TRP53-deficient mice housed at 22ºC and kept 520 
on a chow diet. In contrast to the findings by Rotter 521 
and colleagues, Ucp1 mRNA and UCP1 protein 522 
levels in iBAT were higher in mice lacking TRP53 523 
indicating that a low sympathetic tone exacerbated 524 
UCP1 expression in the TRP53-deficient mice. 525 
Furthermore, expression of other iBAT marker 526 
genes was not impaired in the TRP-deficient mice 527 
(Figure 4B-D). 528 
Interestingly, when assessing iWAT for expression 529 
of Ucp1 and several other thermogenic markers, we 530 
found an upregulated expression of PPARGC1a and 531 
PPARGC1b target genes but neither Ppargc1a nor 532 
Ppargc1b mRNAs in mice lacking TRP53 compared 533 
to wildtype mice on a high-fat diet (Figure 5A). Of 534 
note, the increased Ucp1 mRNA level in the iWAT 535 
of TRP53-deficient mice was accompanied with an 536 
augmented number of UCP1 protein 537 
immunoreactive multilocular cells with increased 538 
staining intensity (Figure 5B).  539 
Furthermore, mice lacking TRP53 had increased 540 
expression in iWAT of genes encoding enzymes 541 
involved in β-oxidative pathways responsible for 542 
degradation of fatty acids, namely the carnitine 543 
palmitoyltransferases (Cpt1a (liver), Cpt1b (muscle 544 
and iWAT) and Cpt2), acyl-Coenzyme A 545 
dehydrogenase, medium chain (Acadm) and 546 
peroxisome proliferator-activated receptor α 547 
(Ppara). Interestingly, this increment was specific 548 
for the adipose tissue as their expression levels were 549 
unaltered in muscle and liver, two tissues with high 550 
β-oxidation capacity (Figure 5C). 551 
We employed indirect calorimetry to investigate 552 
whether oxygen consumption, as would be 553 
predicted, was increased in the TRP53-deficient 554 
mice. However, no significant differences in oxygen 555 
consumption, CO2 production or respiratory 556 
exchange ratio (RER) in TRP53-deficient mice were 557 
observed (Figure 6A-C), a result possibly reflecting 558 
that small changes in energy expenditure which over 559 
time significantly result in altered adipose mass 560 
cannot be determined by relative short-time indirect 561 
calorimetry measurements (7, 50, 56).  562 
Collectively, these data indicate that energy 563 
expenditure is increased in TRP53-deficient mice, 564 
and that p53 regulates β-oxidative capacity in a 565 
tissue-specific manner. This notion was supported 566 
by the finding that the expression of Synthesis of 567 
Cytochrome c Oxidase 2, (Sco2) involved in 568 
mitochondrial respiration was similar in iWAT of 569 
wildtype and TRP53-deficient mice, but decreased 570 
in livers of mice lacking TRP53 (Figure 6D), the 571 
latter being in accordance with previous findings 572 
(40).  573 
 574 
TRP53-deficient adipocytes express UCP1 575 
The data above indicated that the ability of TRP53-576 
deficient mice to resist high-fat feeding-induced 577 
obesity could rely at least partially on the increased 578 
activation of the thermogenic program in iWAT.  579 
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Mouse embryonic fibroblasts (MEFs) have been 580 
instrumental in deciphering adipocyte differentiation 581 
and function. We therefore speculated, if MEFs 582 
lacking TRP53 had increased propensity to express 583 
Ucp1. In agreement with earlier observations (22, 584 
43, 44), MEFs lacking TRP53 had an augmented 585 
adipogenic potential (Figure 7A+B). Interestingly 586 
and in agreement with the in vivo findings, we 587 
observed a dramatic increase in Ucp1 mRNA levels, 588 
but no differences in the expression of mRNAs 589 
encoding PPARGC1a and PPARGC1b in response 590 
to differentiation of MEFs with an adipogenic 591 
cocktail including rosiglitazone (Figure 7C). To 592 
compensate for differences in the degree of 593 
adipocyte differentiation between the TRP53-594 
deficient and the wildtype MEFs, the expression 595 
levels of Ucp1 mRNA and mRNAs encoding 596 
PPARGC1a and PPARGC1b were calculated 597 
relative to levels of mRNA encoding PPARγ2. The 598 
increment in Ucp1 mRNA was accompanied by 599 
augmented expression levels of other genes 600 
associated with thermogenesis and known 601 
PPARGC1a and PPARGC1b target genes (Figure 602 
7D) (13, 57). 603 
A number of other adipose markers previously 604 
reported to characterize either white or brown 605 
adipocytes (53) were not specifically repressed or 606 
enriched, respectively, in TRP53-deficient 607 
adipocytes differentiated in the presence of 608 
rosiglitazone (Figure 7E) showing that the TRP53-609 
deficient adipocytes did not resemble the classic 610 
interscapular brown adipocytes, suggesting that they 611 
more closely resemble BRITE/beige adipocytes. 612 
Of note, inclusion of rosiglitazone during 613 
differentiation with the standard MDI cocktail of 614 
adipogenic inducers was necessary for induction of 615 
UCP1 in the MEF-derived TRP53-deficient 616 
adipocytes (Figure 7F). 617 
Retinoic acids (RAs) and cAMP have previously 618 
been reported to augment Ucp1 expression in brown 619 
adipocytes in cultures (11-13). We therefore 620 
examined if treatment with 9-cis RA and the cAMP 621 
elevating compound isoproterenol would be 622 
sufficient to induce Ucp1 expression in the MEF-623 
derived TRP53-deficient adipocytes. Interestingly, 624 
and in contrast to wildtype adipocytes, treatment of 625 
MDI-differentiated MEF-derived TRP53-deficient 626 
adipocytes with 9-cis RA and isoproterenol 627 
augmented Ucp1 mRNA expression. This happened 628 
without an increase in the expression of mRNAs 629 
encoding PPARGC1a and PPARGC1b (Figure 8A). 630 
Still, expression of other PPARGC1a and PPARG1b 631 
target genes was also increased in the TRP53-632 
deficient adipocytes upon 9-cis RA and 633 
isoproterenol treatment (Figure 8B). 634 
SV40 large T antigen is known to bind and 635 
sequester various proteins including the 636 
retinoblastoma protein (pRB) and p53 (1). We have 637 
previously shown that ectopic expression of the TAg 638 
dramatically increased the expression of Ucp1 in 639 
white adipocytes (23). We therefore sought to 640 
examine if inhibition of p53 was needed for the 641 
ability of TAg to induce Ucp1 mRNA levels. 642 
A mutant designated TAg K1 contains an amino 643 
acid substitution in the pRB consensus binding 644 
motif (LxCxE) and cannot bind to pRB family 645 
members whereas the TAg Δ (deletion 434-444) 646 
mutant holds a mutation in the bipartite p53-binding 647 
domain and cannot inactivate p53 (9, 32). In 648 
agreement with our earlier work (23), ectopic 649 
expression of Tag in both C3H10T1/2 cells and 650 
wildtype MEFs increased Ucp1 mRNA expression, 651 
whereas expression of TAg K1 did not. 652 
Interestingly, although forced expression of TAg Δ 653 
did increase Ppargc1a mRNA levels, expression of 654 
Ucp1 was not induced suggesting that p53 655 
inactivation in this setting is necessary to increase 656 
Ucp1 mRNA expression (Figure 9). 657 
To further substantiate the negative impact of 658 
TRP53 on energy consumption in adipocytes, we 659 
isolated primary cells from iWAT as wells as iBAT 660 
depots from wildtype and TRP-deficient mice and 661 
differentiated them in vitro. We then assessed 662 
oxygen consumption and expression of several 663 
thermogenic and β-oxidative genes. Both basal and 664 
isoproterenol-stimulated oxygen consumptions were 665 
higher in cells from iWAT whereas only 666 
isoproterenol oxygen consumption was higher in 667 
primary adipocytes from iBAT (Figure 10A+C). Of 668 
note, chemical uncoupling by addition of FCCP 669 
increased oxygen consumption rate to the same level 670 
in both wildtype and TRP53-deficient adipocytes. 671 
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Thus, the FCCP-induced increase in oxygen 672 
consumption rate was less in the  TRP53-deficient 673 
than in wildtype adipocytes, further demonstrating a 674 
higher level of uncoupled respiration in the TRP53-675 
deficient adipocytes (Figure 10A+C)   Reflecting the  676 
in vivo data, several genes involved in 677 
thermogenesis, mitochondrial electron transport, and 678 
β-oxidation were also upregulated in the in vitro 679 
differentiated iWAT-derived adipocytes lacking 680 
TRP53. However, in contrast to the in vivo results, 681 
expression of Ppargc1a and Ppargc1b mRNAs were 682 
higher in  TRP53-deficient adipocytes than wildtype 683 
adipocytes, possibly reflecting a derepression the 684 
Ppargc1a and Ppargc1b promoters in the absence of 685 
p53 (51) in the setting of adipocytes differentiated 686 
from primary cells (Figure 10B+D). Furthermore, 687 
primary cells from iBAT also differentiated into 688 
adipocytes having higher expression of Ucp1 689 
mRNA, and mRNAs encoding proteins involved in 690 
mitochondrial electron transport (Figure 10D), 691 
suggesting a general adipocyte-related effect of p53. 692 
In this context it is noteworthy that expression of 693 
Sco2 mRNA was not impaired in the in vitro 694 
differentiated primary adipocytes derived from 695 
iWAT or iBAT of TRP53-deficient mice (Figure 696 
10B+D) 697 
Collectively, our results indicate that the absence of 698 
p53 confers adipocytes with an increased ability to 699 
express UCP1.  700 
 701 
p53 is a negative regulator of PPARG1a and 702 
PPARGC1b  activity 703 
Similar to iWAT of TRP53-deficient mice, MEF-704 
derived in vitro differentiated adipocytes lacking 705 
TRP53 were able to augment Ucp1 expression 706 
without a concomitant increase in the levels of 707 
mRNAs encoding PPARGC1a and PPARGC1b. 708 
Additionally, mutation of the p53 binding site in 709 
TAg prevented its ability to induce Ucp1 expression 710 
despite augmented Ppargc1 mRNA levels. 711 
Still, we observed increased expression of genes 712 
previously shown to be regulated by PPARGC1a 713 
and PPARGC1b both during the rosiglitazone-714 
induced differentiation of MEFs and by the 9-cis 715 
RA/isoproterenol treatment. The increased Ucp1 716 
levels in TRP53-deficient MEF-derived adipocytes 717 
might therefore occur independently of augmented 718 
expression of the Ppargc1a and Ppargc1b, 719 
suggesting that p53 apart from effects on the 720 
Ppargc1a (50) and possibly Ppargc1b promoters 721 
might directly repress the activity of PPARGC1a 722 
and PPARGC1b. Lentiviral shRNA-mediated 723 
knockdown of Ppargc1a, which also led to a 724 
decrease of Ppargc1b expression, showed that 725 
expression of Ucp1 in the TRP53-deficient 726 
adipocytes was indeed dependent on the two 727 
cofactors (Figure 11A). 728 
We therefore examined if p53 could modulate the 729 
activity of the cofactors directly. Not only was 730 
wildtype p53 able to decrease the activity of GAL4-731 
fused PPARGC1a (Figure 11B). A DNA-binding 732 
deficient mutant (p53 R175D) also lowered 733 
PPARGC1a activity. The mutant was, however, less 734 
efficient despite similar levels of expression (Figure 735 
10B). Furthermore, when performing GST-pull 736 
down with fragments of PPARGC1a, we were able 737 
to pull down in vitro translated p53. More 738 
specifically, p53 bound to two regions of 739 
PPARGC1a, aa202-403 and aa551-797 (Figure 740 
11C). 741 
If p53 regulates Ucp1 expression independently of 742 
its DNA-binding ability, ectopic expression of the 743 
p53 R175D mutant should lower Ucp1 mRNA 744 
levels in MEFs lacking TRP53 differentiated in the 745 
presence of rosiglitazone. Indeed, forced expression 746 
of p53 R175D lowered Ucp1 mRNA expression 747 
(Figure 12A) showing that the ability of TRP53 to 748 
regulate expression of Ucp1 was not dependent on 749 
its ability to bind DNA. 750 
Besides regulating the expression of Ucp1, 751 
PPARGC1a and PPARGC1b are also involved in 752 
the regulation of several genes involved in oxidative 753 
phosphorylation in adipocytes (13, 57). In keeping 754 
with the suggested negative impact of p53 on 755 
PPARGC1a and PPARGC1b, ectopic expression of 756 
p53 R175D lowered both the expression levels of 757 
the rate-limiting enzymes in β-oxidation as well as 758 
β-oxidation itself in the TRP53-deficient adipocytes 759 
(Figure 12B+C). 760 
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Collectively, our data indicate that augmented 761 
activity of PPARGC1a and PPARGC1b contributed 762 
to the increased capacity of TRP53-deficient 763 
adipocytes to express Ucp1. 764 
 765 
DISCUSSION 766 
Albeit the tumor suppressor p53 has been most 767 
intensely studied in the context of cancer 768 
development, it is now acknowledged that p53 is 769 
involved in several aspects of metabolism (19). Here 770 
we expand the metabolic regulatory functions by 771 
showing that TRP53 can regulate Ucp1 expression 772 
through inhibition of PPARGC1a and PPARGC1b 773 
activity. This interplay could, at least partly, explain 774 
the resistance to high-fat feeding-induced obesity of 775 
TRP53-deficient mice as these mice had increased 776 
levels of Ucp1 in their iWAT. Although the 777 
augmented level of Ucp1 expression in iWAT 778 
probably is an important contributor, it is likely that 779 
other systemic metabolic changes contribute to the 780 
high-fat resistant phenotype of TRP53-deficient 781 
mice. Defective oxidative metabolism in other 782 
organs, such as the liver, can augment the energy 783 
flux through futile cycles contributing to the 784 
metabolic inefficiency of these mice. 785 
Surprisingly, our findings are contradictory to a 786 
recent article by Rotter and colleagues reporting that 787 
TRP53-deficient mice gained more weight 788 
compared with wildtype mice when challenged with 789 
a high-fat diet. This phenotype was explained by 790 
defective development of and UCP1 expression in 791 
the iBAT (43). This finding contrasts a previous 792 
study showing efficient differentiation of 793 
preadipocytes isolated from brown adipose tissue of 794 
TRP53-deficient mice. These adipocytes had high 795 
expression of UCP1 (28). In keeping with the latter 796 
report, we did not observe defects in neither iBAT 797 
appearances (data not shown) nor Ucp1 expression 798 
in mice lacking TRP53 (Figure 4A). Furthermore, 799 
we did not observe impaired in vitro differentiation 800 
of cells from the stromal vascular fraction of iBAT 801 
of TRP53-deficient mice. Compared with in vitro 802 
differentiated adipocytes derived from the stromal 803 
vascular fraction isolated from wildtype mice, the 804 
TRP53-deficient adipocytes also exhibited higher 805 
expression of mRNAs encoding UCP1 and proteins 806 
involved in mitochondrial electron transport. 807 
Finally, reflecting the increased expression of these 808 
mRNAs, we were able to demonstrate increased 809 
oxygen consumption rate and higher levels of 810 
uncoupled respiration of in vitro differentiated 811 
adipocytes derived from the stromal vascular 812 
fraction of both iWAT and iBAT from TRP53-813 
deficient mice compared to those derived from 814 
wildtype mice. 815 
One possible explanation for these contradictory in 816 
vivo findings could be different housing 817 
temperatures since differences in housing 818 
temperatures previously have been shown to result 819 
in opposing findings examining UCP1-deficient 820 
mice (15, 18, 37). Thus, when housed at room 821 
temperature, UCP1-deficient mice do not gain 822 
weight relative to wildtype mice. However, when 823 
the mice are housed at thermoneutrality, the UCP1-824 
deficient mice gained more weight than their 825 
wildtype counterparts (18). For this study, we 826 
housed mice at thermoneutrality (28 ºC) whereas in 827 
the study by Rotter the mice were kept at 22-23 ºC 828 
(Rotter, personal communication). It is difficult to 829 
explain how differences in housing temperatures 830 
could negatively affect the development of iBAT. 831 
However, in order to examine whether the divergent 832 
results could be due to different housing 833 
temperatures, we performed an additional 834 
experiment where wildtype and TRP53-deficient 835 
mice where housed at 22ºC. This experiment 836 
revealed that expression of Ucp1 and other markers 837 
of iBAT was not impaired in mice lacking TRP53. 838 
Rather, expression of Ucp1 mRNA and UCP1 was 839 
augmented in the TRP-deficient mice compared to 840 
wildtype mice. 841 
Differences in mouse strains may affect the impact 842 
of TRP53 deficiency. Thus, it has been shown that 843 
the C57BL/6N strain differs with respect to several 844 
metabolic parameters from the C57BL/6J strain 845 
(55). However, in both studies C57BL/6J mice were 846 
used (Rotter, personal communication). Small 847 
difference may exist between the two lines used, but 848 
even so, it seems unlikely that such differences 849 
would explain the different results. 850 
In our study, the mice were caged individually, 851 
whereas the mice used in the study of Rotter and 852 
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coworkers appeared to be co-caged except for the 853 
periods of measurements of food intake and 854 
detection of locomotor activity, where the mice were 855 
caged individually (43). Differences between co-856 
caging and individual caging have been reported to 857 
affect physiological parameters likely to influence 858 
metabolic phenotypes (17, 20, 31). 859 
Finally, recent publications have emphasized that 860 
the gut microbiota differs significantly between 861 
mice procured from different vendors and kept in 862 
different animal facilities (58, 63). Such differences 863 
in the gut microbiota may strongly influence the 864 
phenotype of genetically identical mice (58). Even 865 
though, differences in the composition of the gut 866 
microbiota may dramatically alter responses to high 867 
fat feeding, it is still difficult to explain how such 868 
differences should affect the developmental path 869 
leading to iBAT formation, also considering that 870 
iBAT is formed prenatally (10).  871 
Despite augmented levels of Ucp1 in the 872 
subcutaneous WAT and a robust decreased weight 873 
gain of TRP53-deficient mice, we observed no 874 
significant difference in the oxygen consumption 875 
between the mice. Still, in vitro differentiated 876 
primary adipocytes from TRP53-deficient mice had 877 
higher oxygen consumption. Minute changes in 878 
energy expenditure due to increased uncoupled 879 
respiration in subcutaneous WAT cannot be 880 
accurately determined during the relative short-time 881 
used for indirect calorimetry measurements. 882 
However, the cumulative effect of small changes in 883 
energy expenditure may over time result in 884 
decreased weight gain (7, 50, 56). But even so, it is 885 
unlikely that the expression of UCP1 in iWAT is the 886 
sole contributor to the obesity-resistant phenotype of 887 
the mice lacking Trp53. 888 
Tissue-specific regulation of metabolic pathways 889 
may also play an important role. In this respect, it is 890 
interesting that p53 is a well-described regulator of 891 
lipid metabolism with the general assumption that 892 
p53 induces lipid catabolism (5, 21). Yet, we 893 
observed an inhibitory effect of TRP53 on fatty acid 894 
oxidation in adipocytes. 895 
We find it conceivable that opposing effects on fatty 896 
acid handling in various tissues can result in a futile 897 
cycle where energy is lost rather than stored. To 898 
isolate the effect the contribution of adipose-p53 to 899 
whole body metabolism, it will be necessary to 900 
study the metabolic adaptability of a fat-specific 901 
knockout of Trp53. 902 
The increased expression of Ucp1 and genes 903 
involved in β-oxidation in the inguinal adipose 904 
depot in TRP53-deficient mice contrasts the 905 
previously reported decreased aerobic respiration in 906 
cells lacking p53 (7). These studies were performed 907 
in cancer cells or liver extracts. An indication that 908 
regulation of metabolism by p53 may be atypical in 909 
adipocytes was first reported by Finkel and 910 
colleagues showing that ablation of Trp53 had a 911 
dramatic effect on the expression of the NAD-912 
dependent deacetylase Sirt1 only in adipose stores 913 
(45). SIRT1 regulates many aspects of metabolism, 914 
such as the response of adipocytes and hepatocytes 915 
to fasting (46, 49). Of note, Ucp1 expression in 916 
TRP53-deficient adipocytes did not seem to be 917 
dependent on an increased SIRT1 activity, as the 918 
SIRT1 inhibitor nicotinamide had no effect on Ucp1 919 
mRNA levels (data not shown). 920 
In keeping with the altered pattern of Sirt1 921 
regulation by TRP53 in adipose stores, differences 922 
in the regulation of Sco2 by TRP53 exist between 923 
liver and adipocytes emphasizing that TRP53 exerts 924 
tissue specific effects on metabolism. Also, 925 
expression of other genes involved in metabolism 926 
previously shown to be regulated by TRP53 in other 927 
tissues was not significantly different in iWAT of 928 
mice lacking TRP53 (data not shown).  929 
Our data indicate that the increased propensity of 930 
TRP53-deficient adipocytes to express Ucp1 at least 931 
in part is the result of derepressed PPARGC1a (and 932 
PPARGC1b) activity and likely also related to a 933 
derepression of the Ppargc1a and Ppargc1b 934 
promoters. Of note, analyzing tissues, we observed 935 
the most pronounced effects in iWAT, whereas lack 936 
of TRP53 had little if any effect on expression of 937 
mRNAs encoding UCP1, PPARGC1a and 938 
PPARGC1b in iBAT in mice housed at 939 
thermoneutrality. In mice housed at 22ºC we 940 
however observed increased expression of UCP1 in 941 
iBAT of Trp53-deficient mice. TRP53 therefore 942 
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serves as an inhibitor UCP1 expression in iWAT 943 
and iBAT. 944 
An inguinal specific positive effect on UCP1 945 
expression has also recently been documented for 946 
PRDM16 (12, 52). In this respect, it is noteworthy 947 
that PRDM16 was suggested to augment 948 
PPARGC1a activity through replacing the 949 
corepressors C-terminal binding proteins (CtBPs) 950 
(30) with which p53 is known to interact (42). 951 
Expression of Ppargc1a and Ppargc1b mRNAs is 952 
higher in iBAT than in iWAT (36, 48). Conversely, 953 
TRP53 is more abundantly expressed in white 954 
compared to brown adipose tissue (29). It therefore 955 
seems possible that a balance between binding of 956 
PPARGC1a to p53-CtBP or PRDM16 in 957 
subcutaneous adipose depots could determine the 958 
level of UCP1 expression in these depots. 959 
Interestingly, an association between p53 and 960 
PPARGC1a was shown to be important during 961 
glucose deprivation where PPARGC1a can act as a 962 
cofactor for TRP53 favoring the induction of genes 963 
regulating cell cycle arrest at the expense of 964 
apoptotic genes (54).  965 
In transient transfection experiments wildtype p53 966 
was more potent than a DNA-binding deficient 967 
mutant in repressing PPARGC1a activity (Figure 968 
10B). It is possible that ectopically expressed 969 
wildtype TRP53 can recruit exogenous PPARGC1a 970 
to genomic DNA and thereby titrate it away from 971 
the artificial reporter. Other possible explanations 972 
include direct binding of wildtype TRP53 to the 973 
reporter plasmid or induction of an auxiliary protein 974 
facilitating the repression. 975 
Besides direct association, it is possible that TRP53 976 
controls PPARGC1a activity via other routes. The 977 
stability of PPARGC1a is regulated by the p38 978 
MAPK (16, 47). TRP53 is known to affect the 979 
activity of the MAPK family (61). Altered p38 980 
activity in the absence of TRP53 could therefore 981 
potentially contribute to the thermogenic phenotype 982 
of adipocytes lacking TRP53. 983 
PPARG1a is also important for activation of 984 
gluconeogenesis in the liver (27, 65). Upon 985 
telomeric stress TRP53 can repress the expression of 986 
Ppargc1a and Ppargc1b leading to several defects 987 
including impaired gluconeogenesis in the liver 988 
(51). Contradictory to this suggested inhibitory 989 
effect of TRP53 on gluconeogenesis, starvation 990 
leads to lower blood glucose levels in TRP53-991 
deficient mice compared with wildtype (45). This 992 
was suggested to be caused by defective starvation-993 
induced expression of Sirt1 in the liver of TRP53-994 
deficient mice as SIRT1 is necessary for proper 995 
gluconeogenesis through modulation of PPARG1a 996 
activity (49).  997 
It is therefore likely that both cell type and the mode 998 
of stress determine the outcome of the PPARGC1a-999 
p53-SIRT1 interplay. During  caloric overload 1000 
associated with high-fat feeding, we observed 1001 
similar expression levels of Ppargc1a and Ppargc1b 1002 
mRNAs as well as mRNAs encoding the two rate-1003 
limiting enzymes in gluconeogenesis, phosphoenol-1004 
pyruvate carboxy-kinase (Pck1) and glucose 6-1005 
phosphatase (G6pc) in livers of wildtype and 1006 
TRP53-deficient mice (data not shown). However, 1007 
due to lack of reliable antibodies recognizing 1008 
PPARGC1a and PPARGC1b we cannot entirely 1009 
exclude the possibility that lack of TRP53 increases 1010 
the level of the proteins, similar to the situation 1011 
observed in RIP140-deficient cells (33). 1012 
Besides its role in regulation of Ucp1 expression, 1013 
TRP53 is involved in other aspects of adipocyte 1014 
biology. Others and we observed increased levels of 1015 
TRP53 in adipose stores of obese mice (Hallenborg 1016 
et al., unpublished data) and (41, 64). This increased 1017 
expression of TRP53 was recently suggested to 1018 
contribute to adipocyte dysfunction during obesity 1019 
by stimulating an inflammatory response through 1020 
NF-κB (41). Based on the findings shown here, it is 1021 
possible that augmented levels of p53 contribute to 1022 
adipocyte dysfunction through inhibition of 1023 
PPARGC1a and PPARG1b activity. 1024 
Its importance in mediating either cell cycle arrest or 1025 
apoptosis upon DNA-damage has given p53 the 1026 
nickname “Guardian of the Genome”. The recent 1027 
findings emphasizing the role of p53 in regulation of 1028 
metabolism suggest that p53 not only guards 1029 
genome integrity but ensures that energy wasting is 1030 
kept to a minimum. 1031 
 1032 
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 1235 
FIGURE LEGENDS 1236 
FIGURE 1. Mice lacking TRP53 gain less weight when fed a high-fat diet. (A-C) Wildtype and TRP53-1237 
deficient mice were fed a chow or high-fat diet for 6 weeks. (A) Weight gain was assessed throughout the feeding 1238 
period. (B) Picture of two representative mice on a high-fat diet. (C) Fat in feces measured by acid hydrolysis. (D) 1239 
Weekly feed intake. (E) Relative feed efficiency calculated by dividing total weight gain with accumulated food 1240 
intake. (F) Serum concentrations of metabolites. TG, triglyceride; FFA, free fatty acids; OH-butyrate, 4-hydroxy 1241 
butyrate. (G) Glucose tolerance test. (H) Insulin tolerance test. (B, C, E, H) *, significance tested using student’s t-1242 
test, p < 0.05. 1243 
 1244 
FIGURE 2. Altered adipose phenotype of Trp53-deficient mice fed a high-fat diet.  (A) Tissue weights in 1245 
wildtype and Trp53-deficient mice kept on chow [C] or high-fat diet [H]. (B) Hematoxilin and eosin stainings of 1246 
eWAT and iWAT from wildtype and Trp53-deficient mice. Bars correspond to 48 μm. (C) Average size of 1247 
adipocytes in eWAT. (D) The estimated, relative number of adipocytes in eWAT in wildtype and Trp53-deficient 1248 
mice. The approximation is based on assumed spherical shape and equal mass density. (E) Hematoxilin and eosin 1249 
stainings of eWAT from wildtype and TRP53-deficient mice. Bars correspond to 24 μm. (F) Expression levels of 1250 
the macrophage markers Emr1 (EGF-like module containing, mucin-like, hormone receptor-like sequence 1) and 1251 
Cd68. (A, C, F) *, significance tested using student’s t-test, p < 0.05. 1252 
 1253 
FIGURE 3. Histological examination reveals fewer lipid droplets in livers from Trp53-deficient mice. (A) 1254 
Hematoxilin and eosin staining of livers from wildtype and Trp53-deficient mice fed a high-fat diet. Bar 1255 
corresponds to 48 μm. (B) mRNA levels of genes encoding ACAA2 and HMGCS2 were measured by real-time 1256 
qPCR. ACAA2, acetyl-CoA acyltransferase 2. HMGCS2, 3-hydroxy-3-methylglutaryl-CoA synthase 2. 1257 
 1258 
FIGURE 4. TRP53 is dispensable for iBAT development. (A) mRNA levels of thermogenic marker genes in 1259 
iBAT of high-fat fed mice kept at thermoneutral conditions. Cox8b, cytochrome c oxidase, subunit VIII. Dio2, 1260 
type II iodothyronine deiodinase. Ppargc1a, peroxisome proliferator-activated receptor γ coactivator-1α. 1261 
Ppargc1b, peroxisome proliferator-activated receptor γ coactivator-1β Ucp1, uncoupling protein 1. Pparg2, 1262 
peroxisome proliferator-activated receptor γ 2. (B) mRNA levels of thermogenic markers in iBAT of wildtype and 1263 
Trp53-deficient mice housed at 22ºC. (C) Protein levels of UCP1 in iBAT of wildtype and TRP53-deficient mice 1264 
p53 inhibits UCP1 expression 
 
19 
 
housed at 22ºC. Annexin II was included as loading control. (D) Quantification of western blots in (C). (B+D) *, 1265 
significance tested using student’s t-test, p < 0.05. 1266 
 1267 
FIGURE 5. Increased expression of mRNA encoding UCP1 in inguinal white adipose tissue in mice lacking 1268 
TRP53. (A) mRNA levels in inguinal, iWAT, adipose stores of thermogenic marker genes. Cycs, cytochrome c. 1269 
Prdm16, PR domain containing 16. (B) Immunohistological examination of UCP1 expression in iWAT from 1270 
wildtype and Trp53-deficient mice. (C) Expression of marker genes involved in β-oxidation in liver, muscle and 1271 
iWAT from wildtype and Trp53-deficient mice fed a high-fat diet for 6 weeks. Acadm, acyl-Coenzyme A 1272 
dehydrogenase, medium chain. Cpt, carnitine palmitoyltransferase. Ppara, peroxisome proliferator-activated 1273 
receptor α. (A, D) *, significance tested using student’s t-test, p < 0.05. 1274 
 1275 
FIGURE 6. Trp53-deficient mice does not display measurable systemic alterations in respiration. (A+B) 1276 
Indirect calorimetric measurements of O2 consumption and CO2 production of wildtype and TRP53-deficient mice 1277 
fed a high-fat diet. (C) Respiratory exchange ratio (RER) on wildtype and TRP53-deficient mice on a high-fat 1278 
diet. (D) mRNA levels of mRNA encoding SCO2 in livers and iWAT of wildtype and TRP53-deficient mice. 1279 
SCO2, synthesis of cytochrome oxidase 2. *, significance tested using student’s t-test, p < 0.05. 1280 
 1281 
FIGURE 7. Trp53-deficient adipocytes have increased propensity to express Ucp1. Wildtype and TRP53-1282 
deficient fibroblasts were induced to undergo adipogenesis in the presence of rosiglitazone. Differentiation was 1283 
evaluated by Oil-Red-O staining of triglycerides (A) or adipocyte marker gene expression by real-time qPCR (B). 1284 
(C-E) Gene expression analyses by real-time qPCR normalized to Pparγ2 mRNA to compensate for differences in 1285 
degree of differentiation. mRNA expression levels of Ucp1, Ppargc1a and Ppargc1b (C), Dio2, Cycs, Cox8b, 1286 
Cox7a1 and Cidea (D) as well as the white and brown adipocyte marker genes (E). Psat, Phosphoserine 1287 
aminotransferase. Serpina3k, Serine protease inhibitor A3K. Prdm16, PR domain containing 16. Otop1, otopetrin-1288 
1. Eva1, protein Eva-1 homolog. Ntrk3, NT-3 growth factor receptor. (F) Wildtype and TRP53-deficient 1289 
fibroblasts were induced to undergo adipogenesis in the presence or absence of rosiglitazone. Level of UCP1 was 1290 
determined by western blotting. TFIIB served as loading control. (B-E) Error bars represent standard deviation. *, 1291 
significance tested using student’s t-test, p < 0.05. 1292 
 1293 
FIGURE 8. Retinoic acid and a β-adrenergic agonist induce Ucp1 expression in TRP53-deficient 1294 
adipocytes. Wildtype and TRP53-deficient MEFs were differentiated in the absence of rosiglitazone and 1295 
stimulated with isoproterenol and 9-cis retinoic acid (9cis+Isoprot) for 24 hours. Shown is induction of Ucp1, 1296 
Ppargc1a and Ppargc1b mRNAs (A) as well as Dio2, Cycs, Cox8b, Cox7a1 and Cidea mRNAs (B). (A, B) Error 1297 
bars represent standard deviation. *, significance tested using student’s t-test, p < 0.05. 1298 
 1299 
FIGURE 9. TAg deficient in p53 binding increased expression of Ppargc1a but not Ucp1. C3H10T1/2 (A) 1300 
and wildtype MEFs (B) were transduced with virus encoding wildtype or mutants versions of TAg, selected and 1301 
differentiated. Expression of Ucp1, Ppargc1a and Fabp4 was determined by real-time qPCR. a, b, significance 1302 
tested using one-way ANOVA, p < 0.05. 1303 
 1304 
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FIGURE 10. In vitro differentiated primary adipocytes lacking Trp53 have higher oxygen consumption and 1305 
expression of genes involved in thermogenesis and β-oxidation. Primary cells from iWAT (A+B) and iBAT 1306 
(C+D) from wildtype and Trp53-/- mice were differentiated into adipocytes. (A+C) Oxygen consumption was 1307 
measured using a Seahorse XF Analyzer. Cells were treated with isoproterenol (I), the uncoupling agent FCCP 1308 
(II) and the inhibitors of the electron transport chain antimycin A+rotenone (III). Oxygen consumption rate is 1309 
depicted relative to levels in cells treated with antimycin A+rotenone. (B+D) mRNA levels of genes involved in 1310 
thermogenesis and β-oxidation were determined by real-time qPCR. *, significance tested using student’s t-test, p 1311 
< 0.05. 1312 
 1313 
FIGURE 11. p53 decreases the activity of PPARGC1a (A) TRP53-deficient MEFs were lentivirally transduced 1314 
with vectors expressing shRNA against lacZ or Ppargc1a, differentiated in the presence of rosiglitazone and 1315 
expression of Ucp1, Ppargc1a and Ppargc1b mRNAs was measured used real-time qPCR. Error bars represent 1316 
standard deviation. a, b, c, significance tested using one-way ANOVA, p < 0.05. (B) TRP53-deficient MEFs were 1317 
transfected with UAS-GAL luciferase-reporter, a vector expressing GAL4-fused to PPARGC1a and either empty 1318 
vector, or different amounts of vectors expressing wildtype p53 or the DNA-binding deficient mutant p53 R175D. 1319 
Luciferase activity was normalized to β-galactosidase activity. Expression of p53 is shown by Western blotting 1320 
below columns. α-tubulin served as loading control. a, b, c, d, significance tested using one-way ANOVA, p < 1321 
0.05. (C) GST-pull down of in vitro translated p53 using GST alone or GST fused to PPARGC1a fragments. Input 1322 
represents 2 % of added in vitro reaction. 1323 
 1324 
FIGURE 12. Ectopic expression of DNA-binding deficient p53 lowers Ucp1 expression and β-oxidative 1325 
capacity of TRP53-deficient adipocytes. TRP53-deficient MEFs were transduced with empty vector or a vector 1326 
expressing p53 R175D, and differentiated in the presence of rosiglitazone. Levels of mRNA encoding UCP1 (A) 1327 
or the β-oxidative enzymes CPT1b, CPT2, ACADM and PPARα (B) were measured using real-time qPCR. Error 1328 
bars represent standard deviation. (C) β-oxidation in the differentiated, transduced cells. Levels of β-oxidation 1329 
were assessed by conversion of palmitate to CO2. *, significance tested using student’s t-test, p < 0.05. 1330 
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